Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BAT-8006 by Bio-Thera Solutions for Epithelial Ovarian Cancer: Likelihood of Approval
BAT-8006 is under clinical development by Bio-Thera Solutions and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData,...
Data Insights
BAT-8006 by Bio-Thera Solutions for Peritoneal Cancer: Likelihood of Approval
BAT-8006 is under clinical development by Bio-Thera Solutions and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase...